Renal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic Syndrome - PubMed
3 hours ago
- #Renal Denervation
- #Metabolic Syndrome
- #Hepatic Steatosis
- Renal denervation (RDN) significantly improves hepatic steatosis in hypertensive patients with metabolic syndrome.
- RDN reduced hepatic steatosis index (HSI) and fatty liver index (FLI) at 3, 6, and 12 months compared to sham procedure.
- No significant difference in HSI and FLI reduction was found based on blood pressure response to RDN.
- UK Biobank data validated the correlation between proton density fat fraction MRI and HSI/FLI.
- Findings suggest sympathetic modulation via RDN may benefit metabolic disorders beyond hypertension.